Surterra Enters $100 Million Cannabinoid Biosynthesis Deal with Intrexon

New Cannabis Ventures
By NCV NewswireJun 18, 2019, 10:19 am265 pts
Intrexon Corporation and Surterra Wellness Partner in $100mm Deal to Advance Commercial Scale Fermentation-based Cannabinoid Production Exclusive Global Agreement to Transform Surterra’s Ability to Produce Specific Cannabinoids to Meet Growing Demand, Boost Innovation and Product Development BUDAPEST, Hungary…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

After Nearly Nine Decades of Lies, Enough Is Enough! 77

Hawthorne Gardening Q3 Revenue Weakens Again 75

Fluence Next-Generation VYPR 4 Top Light Now Shipping to Global Cannabis Cultivators 73

Summer Edibles to Beat the Heat 73

Georgia Lawmakers Launch Study Of Medical Marijuana And Hemp Policies To Prepare For 2026 Session 73

Report: Cannabis Dispensary and Vape Shop Workers Happiest in the Nation 70

Connecticut Files $2.5M Lawsuit Over Fraudulent Cannabis License-for-Sale Scheme 69

‘Laughable’: New York pot market sees another major blunder 67

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.